Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 13/20 | 0.73 |
| ▸ | ELOC | Q15369 | 2/20 | 0.73 |
| ▸ | ELOB | Q15370 | 2/20 | 0.73 |
| ▸ | EGFR | P00533 | 3/20 | 0.62 |
| ▸ | BRD4 | O60885 | 2/20 | 0.61 |
| ▸ | NAMPT | P43490 | 4/20 | 0.60 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22325294 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL22186170 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL22186167 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL24201266 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL21308313 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL24201263 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL29290867 | 0.97 | VHL (0.76) | VHLELOCELOBEGFRBRD4 | |
| SCHEMBL23304123 | 0.96 | VHL (0.67) | VHLELOCELOBEGFRHDAC3 | |
| SCHEMBL23304120 | 0.96 | VHL (0.67) | VHLELOCELOBEGFRHDAC3 | |
| SCHEMBL24926153 | 0.96 | VHL (0.67) | VHLELOCELOBEGFRHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709370-A2 | STAT DEGRADERS AND USES THEREOF | Recludix Pharma, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024233639-A2 | STAT DEGRADERS AND USES THEREOF | RECLUDIX PHARMA, INC. (US) | 2024-11-14 | — | — | WO | disclosed |